Factors of late respiratory support or oxygen weaning in infants with bronchopulmonary dysplasia
- PMID: 39451000
- PMCID: PMC11740655
- DOI: 10.1002/ppul.27367
Factors of late respiratory support or oxygen weaning in infants with bronchopulmonary dysplasia
Abstract
Objectives: Bronchopulmonary dysplasia (BPD) is the most common complication in preterm infants. This study aimed at identifying factors associated with early or with late or weaning failure from respiratory support or oxygen (O2) in preterm infants with BPD requiring respiratory support or O2 therapy after discharge from the neonatal intensive care unit (NICU).
Methods: This retrospective study was conducted in the NICU of a tertiary hospital, in infants born before 32 weeks of gestation between 2012 and 2021, and discharged from the NICU with a respiratory support (tracheostomy [TT], invasive ventilation [IV], Non-IV [NIV], continuous positive airway pressure [CPAP], high flow nasal canula [HFNC]) or O2 therapy for BPD. Univariate and multivariate analyses were performed to identify factors associated with early weaning (before 6 months postmenstrual age [PMA]) or late (after 6 months PMA) and weaning failure.
Results: Among the 53 infants included (2% TT, 2% IV, 11% NIV, 25% CPAP or HFNC, 60% O2 at NICU discharge), 23 (43%) were weaned from respiratory support or O2 before 6 months PMA and 39 (73%) before 12 months PMA. IV duration during NICU stay and postnatal steroid treatment were identified as factors associated with a late or weaning failure (OR 1.03, p = .04 and OR 4.11, p = .023, respectively).
Conclusion: In this study, nearly half of preterm infants with severe BPD were weaned from respiratory support or O2 before 6 months PMA. IV duration and postnatal steroid treatment during NICU stay were associated with a late or weaning failure.
Keywords: bronchopulmonary dysplasia; infants; prematurity; respiratory support; weaning.
© 2024 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Liberation from Respiratory Support in Bronchopulmonary Dysplasia.J Pediatr. 2025 Jul;282:114390. doi: 10.1016/j.jpeds.2024.114390. Epub 2024 Nov 8. J Pediatr. 2025. PMID: 39521174
-
A randomized pilot study comparing the role of PEEP, O2 flow, and high-flow air for weaning of ventilatory support in very low birth weight infants.Pediatr Neonatol. 2018 Apr;59(2):198-204. doi: 10.1016/j.pedneo.2017.02.005. Epub 2017 Sep 6. Pediatr Neonatol. 2018. PMID: 28943321 Clinical Trial.
-
Respiratory support and bronchopulmonary dysplasia in infants born at 22-26 weeks gestation in Sweden, 2004-2007 and 2014-2016.Eur Respir J. 2025 Jan 16;65(1):2401203. doi: 10.1183/13993003.01203-2024. Print 2025 Jan. Eur Respir J. 2025. PMID: 39510555 Free PMC article.
-
Nasal high flow therapy for primary respiratory support in preterm infants.Cochrane Database Syst Rev. 2023 May 5;5(5):CD006405. doi: 10.1002/14651858.CD006405.pub4. Cochrane Database Syst Rev. 2023. PMID: 37144837 Free PMC article. Review.
-
High Flow Nasal Cannula for Weaning Nasal Continuous Positive Airway Pressure in Preterm Infants: A Systematic Review and Meta-Analysis.Neonatology. 2024;121(3):359-369. doi: 10.1159/000536464. Epub 2024 Feb 27. Neonatology. 2024. PMID: 38412846 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical